chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vaccine was stored after expiration date in the refrigerator; 606 doses were given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and PRODUCT STORAGE ERROR (Vaccine was stored after expiration date in the refrigerator) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Nov-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored after expiration date in the refrigerator). At the time of the report, EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and PRODUCT STORAGE ERROR (Vaccine was stored after expiration date in the refrigerator) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.    No concomitant medication was reported by the reporter. No adverse events reported.  No temperature excursion of the product was reported. There was no product complaint associated. Vaccine was refrigerated on 29-Oct-2021. No treatment information provided.   This case was linked to MOD-2022-491837 (Patient Link).
Myalgia, Fever, NauseaVomiting, chills and above resolved day after vaccination Narrative:  Other Relevant History:
pt recvd vax 26AUG92 & travel to Ecuador SEP92 contracted typhoid fever & required treatment w/an ATB; pt recovered;
Received Menactra 07/21/2005. C/O gen ill feeling 07/22/2005.  C/O fever 101.3 - 104, severe head pain, stiff neck, nausea, photophobia 07/23/2005. Seen in ER to take Tylenol/Ibuprofen, DX by ER physician per patients Mom, "reaction to the vaccine". Current status unknown at this writing.  Patient was "sleeping".
On June 12, I passed out or collapsed while running errands. I was conscious, but fell to the ground and was not able to sit up and was very dizzy. An ambulance and paramedics were called. They monitored by vitals signs and after about 30 minutes determined I could drive home. The following Monday, June 14, I saw my doctor. I was having symptoms of diverticulitis, so she treated me for that and thought the incident on the 12th may be related. The diverticulitis symptoms improved with antibiotics, but I remained dizzy, weak, and generally feeling weak. I returned to see a different doctor on June 18 who ran some tests and thought I may be having a cardiac incident. I was sent to the Emergency Room, where they determined I had an inner ear issue. I have since seen an ENT and am working to determine the cause. I have remained dizzy to various degrees for about a month. The issue is slowly getting better now.
PATIENT REPORTS EXPERIENCING LOSS OF HEARING ON 08/03/2022 AFTER RECEIVING VACCINE ON 08/01/2022. PATIENT NOW ON PREDNISONE
arm felt hot to the touch, felt arm heavy very difficult to move the arm, felt feverish, took temperature but no fever, but hot to the touch, lots of chills, nausea, body aches.  Took some tylenol and at night it started getting a little better.  This morning the injection site is red and is sore but I can move my arm again.
suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by the patient for herself/himself. The age at vaccination was not reported. The patient reported that, he/she got had Shingle shots and got shingle twice. This case was considered as suspected vaccination failure, since the details regarding the completion of primary vaccination schedule, time to onset for event and laboratory confirmation for shingles were not provided.
Sore arm; nausea; This is a spontaneous report from a contactable nurse reporting for self.  A 43-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), Lot# EH9899, via an unspecified route of administration in the right arm on 19Dec2020 at 15:30 (at the age of 43-years-old), as a single dose for COVID-19 immunization. The patient was not pregnant at the time of vaccination. The vaccine was administered in a hospital facility. There was no prior COVID-19 vaccination. The patient was not diagnosed with COVID-19 prior to vaccination & not COVID tested post vaccination. Medical history was none.  Concomitant medications were not reported; however, there were no other medications the patient received within 2 weeks of the vaccination. The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. There were no known allergies to medication, food, or other products. The patient experienced sore arm for 24 hours, then from about 34-72 hours had nausea. The onset date and time for the events was reported as 19Dec2020 at 15:30. The events were reported as non-serious. There was no treatment for the events. The patient recovered from the sore arm  and nausea on an unspecified date.
Persistent left sided headache assoc. w/ nausea, left sided face discomfort.
Pain, muscle weakness, and tenderness at the injection site that has persisted 4+ months.
I got the shots last summer / got shingles this spring! / Suspected Vaccination failure; Got shingles this spring!; This case was reported by a consumer via media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, less than a year after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: This case was reported by patient himself/herself. The age at vaccination was not reported. The patient stated he/she got the Shingles shots last summer and still got shingles this spring. The patient stated as not 100 percent effective. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization and laboratory confirmation were not provided.
On the last day of the pills I had an itchy rash all over my body and went to the emergency room at Hospital
worse reactions to the second dose than to the first one; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (worse reactions to the second dose than to the first one) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ADVERSE REACTION (worse reactions to the second dose than to the first one). At the time of the report, ADVERSE REACTION (worse reactions to the second dose than to the first one) outcome was unknown.            Concomitant product use was not provided by the reporter. Treatment information was not provided. Lab details were not provided.
6 year old female with PMH of asthma who presented to the ED 8/14 due to fever, sore throat, cough, congestion for 4 days. Day prior patient had been refusing to walk due to calf pain. Upon presentation to the ED vital signs were stable, patient was complaining of painful ambulation. Labs were ordered. No leukocytosis or anemia noted, slight AST elevation. No electrolyte abnormalities. ESR was WNL, slightly elevated CRP at 9.9. COVID-19 positive with elevated CK at 633. Patient was given fluids, steroids, and breathing treatment. Toradol for calf pain. Admitted to the floor for further management. Patient did well overnight. Medically stable for discharge.
When Lead Vaccinator drew the 1.8 ml diluent from the vial, she inadvertently injected it back into the diluent vial. She then withdrew the COVID vaccine dose from the Pfizer vial. Patient received 0.3 ml of undiluted vaccine in left deltoid. Error was not realized until after patient left and the vaccinator realized there were no other doses available to draw from the COVID vaccine vial. Looked at diluent vial and saw diluent was in bottle. Clinic contacted Physician contact and was informed that patient should be informed of error and may experience more soreness in arm but no serious adverse reactions from overdose. Patient informed and informed as directed. Reeducation given to Lead Vaccinator. Diluent vial removed from draw area once diluent was removed from vial after incident to prevent further incidents from occurring.
This spontaneous report as received from a registered nurse refers 3 months infant, of unknown gender. Medical history and concurrent conditions were not reported. On 17-JAN-2014, the patient was vaccinated with dose 2 of ROTATEQ lot #J007283; expiration date: 27-SEP-2014 (dose, strength and route were not reported). Secondary and concomitant therapies were not reported. Nurse called and stated that improperly stored ROTATEQ was administered to patient. No adverse effects reported. The nurse reported that vaccine dose received by patient was a vaccines improperly stored as follows: On 13-JAN-2014, ROTATEQ was stored outside of recommended temperatures for 2 hours (2 pm - 4 pm) the temperature recorded was 50 degrees F. On 18-JAN-2014, ROTATEQ was stored outside of recommended temperatures for 2 hours (2 pm - 4 pm) the temperature recorded was 49.1 degrees F. On 10-FEB-2014, ROTATEQ was stored outside of recommended temperatures for 6 hours (12 pm - 6 pm) the temperature recorded was 51.8 degrees F. On 16-FEB-2014, ROTATEQ was stored outside of recommended temperatures for 5 hours (12 pm - 5 pm) the temperature recorded was 51.8 degrees F. On 22-FEB-2014, ROTATEQ was stored outside of recommended temperatures for 4 hours (2 pm - 6 pm) the temperature recorded was 52.7 degrees F. On 09-MAR-2014, ROTATEQ was stored outside of recommended temperatures for 2 hours (12 pm - 10 pm) the temperature recorded was 55.4 degrees F. On 15-MAR-2014, ROTATEQ was stored outside of recommended temperatures for 6 hours (8 am - 2 pm) the temperature recorded was 50 degrees F. On 16-MAR-2014, ROTATEQ was stored outside of recommended temperatures for 20 hours (2 am - 10 pm) the temperature recorded was 64.4 degrees F. On 17-MAR-2014, ROTATEQ the temperature reading on the morning was 64.8 degrees F. The total of hours stored outside of recommended temperatures was 55 hours. This is one of several reports received from the same reporter. Additional information has been requested.
Arm swelling ( double in size), heavy, and throbbing with or without movement. Started a couple hours after vaccine, went to bed that night and woke with minor pain in the arm and considerable less swelling.
Patient returned to the pharmacy ~ 40 min. after receiving the flu shot. She said she felt lightheaded and felt that she couldn't drive home. I asked her about her breathing, checked for a rash & took her BP (179/99). We sat for a while & she was still shaky. I called 911 & the paramedics came to check her out.
Lump at the injection site. It hurts even when I am not touching it, but when I touch it it is worse; Hard lump at the injection site; A lot of generalized swelling; Warm to touch; This is a spontaneous report from a contactable consumer (patient). A 34-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: EL9266, expiration date was not reported), via an unspecified route of administration, administered in right arm on 21Feb2021 (at the age of 34-years-old) as dose 2, single for covid-19 immunization. The patient medical history and no concomitant medications. The patient historical vaccine included first dose of BNT162B2 (lot number was not reported (First dose: Unclear handwriting for lot, could be EL9292 or EL0202, she is unsure but believes it starts with EL like the second dose), expiration date was not reported (There is no expiration date or NDC number)), via an unspecified route of administration, administered in left shoulder on 29Jan2021 (at the age of 34-years-old) as dose 2, single for COVID-19 immunization and experienced severe body aches (she take hard core pain medications, the body aches were so bad my medications didn't touch it, they lasted 8 days). It was reported that, the patient was calling about the Covid vaccine. The patient got the 2nd Pfizer covid vaccine shot last Sunday, 21Feb2021. She had the same side effects for the most part from the first dose. She have a hard lump at the injection site on 25Feb2021. It hurts even when I am not touching it, but when I touch it is worse. It was warm to touch, but that went away in a day or two. She was not sure when the lump started on her arm this time. She had a lot of generalized swelling immediately following the vaccine that started within a couple of hours (on 21Feb2021). She was not sure when the lump started. She have never had anything like this before. She asked is this a known side effect. The patient was going to sound crazy, she promises she's not. The patient states that she got the second dose of the vaccine on Sunday, not this past Sunday but the one before that, and then developed a lump at the injection site, not swelling but an actual lump that moves back and forth. The patient had the same symptoms as the first time she received the vaccine but now has this lump. It was clarified that she did have overall swelling that started a few hours after injection, the swelling went down and then there was a lump. When asked if she recovered completely or recovered with lasting effects from the general swelling at the injection site, the patient states that she recovered on 25Feb2021 but doesn't know if the lump is considered a lasting effect. Her vaccine card only has Pfizer, the lot numbers, and the where she received it. The outcome of the event warm to touch was recovered on an unspecified date of 2021, outcome for event a lot of generalized swelling was recovered with sequel on 25Feb2021, outcome for event hard lump at the injection site was not recovered and outcome was unknown for other event.  No follow-up attempts are possible. No further information is expected.
very, like pain to the point that my arm could not function; affected my blood pressure; was about 130 over 80; I have been experiencing pain in my neck and my shoulder and back; I have been experiencing pain in my neck and my shoulder and back; I have been experiencing pain in my neck and my shoulder and back; Chest pain; it getting ahead to the point in time that I felt like I can possibly; This is a spontaneous report from a contactable consumer or other non hcp. A 26-years-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection, Batch/Lot Number: FC3183), via an unspecified route of administration on 24Aug2021 (at the age of 26-years-old) as dose 2, single for COVID-19 immunisation. Medical history included weight loss. Concomitant medication included metformin taken for weight loss. The patient received first dose of BNT162B2 on 03Aug2021 (Lot no: FC3180) for COVID-19 immunisation. On an unknown date the patient experienced very, like pain to the point that my arm could not function, affected my blood pressure; was about 130 over 80, i have been experiencing pain in my neck and my shoulder and back and chest pain; it getting ahead to the point in time that i felt like i can possibly. The patient reported that she got her second vaccine last Tuesday and noticed after weeks around Thursday and Friday, noticed also a very, like pain to the point that her arm could not function, so her mother checked her blood pressure and it was about 130 over 80 and the worst is it got was on Sunday she took Tylenol extra strength and then on Sunday when she was going to her workplace it helped a bit, she has been experiencing pain in her neck and her shoulder and back and like pain. She reported that the most alarming thing for her is just the chest pain and then it getting ahead to the point in time that she felt like she can possibly pass out. She was just wondering if these were a symptoms that have come across and if it is alarming to go to an urgent care or to an emergency room. Patient was told about the role of Pfizer Medical Information Department. Patient reported that her mom checked her blood pressure on Friday when she started to feel that the symptoms increased and it was 130 over 80 she did not check it today but it seemed like may elevate. She takes vitamins and Metformin for weight loss. The patient reported no treatment and did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Therapeutic measures were taken as a result of affected my blood pressure; was about 130 over 80. The patient underwent lab tests and procedures which included blood pressure measurement: 130/80 mmhg on an unknown date. The outcome of all the events was unknown.
Seizure events for three consecutive times in one week. Urticaria, vomiting, diarrhea, hands and feet cramps and intense headaches. I actually still have headaches as of today. On January 24th I went to the Emergency Room for the events that I just mentioned. Also, I am currently going for treatment with a Neurologist
Vaccine administered past expiration. Vial moved from freezer to fridge on 10/7/2021 with a 30-day expiration on 11/6/2021.
on Day 6 of my vaccine, I thought I had an allergic reaction to a shirt I was wearing. I noticed hives on my arm so I took Benadryl. then I started to notice huge swelling to my chin, took 2 Benadryl's and fell asleep. Then when i woke up I had swelling to my left hand with  hives on my arm. I again took 2 Benadryl's. Then my lip started swelling on the upper or lower quadrant with some drooping and swelling sensation. I did a telemedicine and the doctor said to continue taking Benadryl. on Saturday I woke up with hives on my torso and arm and I continued to take Benadryl and then a different part of my lip was swelling up. On Sunday, 1/2 of my tongue was swelling up, I took Benadryl again and my swelling started to wear off a bit. I took Benadryl and my symptoms started to wear down.  On Wednesday 03-24-21, again I had swelling to my lip but no hives.
Patient received vaccine on 11/16/12 at pharmacy. Patient noticed rash/redness at the injection site of the PNEUMOVAX. On 11/18/12 patient went to a walk in clinic then ER and received antibiotics for a cellulitis reaction. On 11/20/12 patient came to pharmacy because reaction was getting worse and spreading.
have a high fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (have a high fever) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (have a high fever). At the time of the report, PYREXIA (have a high fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were reported. No Treatment medications were reported.
achiness; soreness; Fatigue; joint pain; chills; nausea; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (achiness), PAIN IN EXTREMITY (soreness), FATIGUE (Fatigue), ARTHRALGIA (joint pain) and CHILLS (chills) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), SIMVASTATIN (ZOCOR) and TESTOSTERONE (ANDROGEL) for an unknown indication.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, the patient experienced PAIN IN EXTREMITY (achiness), PAIN IN EXTREMITY (soreness), FATIGUE (Fatigue), ARTHRALGIA (joint pain), CHILLS (chills) and NAUSEA (nausea). At the time of the report, PAIN IN EXTREMITY (achiness), PAIN IN EXTREMITY (soreness), FATIGUE (Fatigue), ARTHRALGIA (joint pain), CHILLS (chills) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information was not reported.
Information has been rec'd from a company representative who rec'd the info from a Nsg concerning a pt who on an unspecified date was vaccinated with 1 dose of MMR vaccine. 2 to 3 wks post vaccine, the pt developed a disseminated measles type rash. The reporter was unable to provide the lot # at the time of the report. The pt sought unspecified medical attention. Also reported was a male pt  (WAES# 00110044) who was vaccinated and experienced similar events. No further info is available.
vaccine given after bud date of 1/18/23 bud date on box was written as 7/31/23 was not correct. no adverse reactions
Tingling nerve pain in extremities developed 2 weeks after vaccine. These symptoms have persisted to today.
Breakthrough COVID: 71-year-old female admitted on July 1st to the ED with a chief c/o abdominal pain, nausea/vomiting and cough with fever. CT of her chest demonstrated a dense right upper lobe pneumonia, pleural effusion and possible worsening of the right upper lobe pneumonia.  The patient is COVID positive. Pt has a hx of COVID positive and fully vaccinated. She has not been on remdesivir or Decadron.   She is also noted to have a history of breast cancer and mild dysplastic syndrome and is neutropenic. She has been on cefepime and vancomycin since admission.he was transferred to ICU due to respiratory distress on 7/4/22 on non-rebreather mask and was orally intubated MV.Pt expired 7/6/22.